(Q44909513)
Statements
1 reference
Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm. (English)
1 reference
Mohammed F Saad
1 reference
Susan Greco
1 reference
Kwame Osei
1 reference
Andrew J Lewin
1 reference
Christopher Edwards
1 reference
Margarita Nunez
1 reference
Rickey R Reinhardt
1 reference
Ragaglitazar Dose-Ranging Study Group
1 reference
1 June 2004
1 reference
1 reference
27
1 reference
6
1 reference
1324-1329
1 reference